Mechanistically, the overexpression of miR-876-3p downregulates the expression of Sox-2, Oct-4, CD133, and CD44 by targeting TMED3, thereby inhibiting the stem cell-like features of GC cells (163). This evidence concerns the gene CD44 and gastric cancer.